Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person PXLP-K314-GPT transaminates PYR to form L-Ala

Class:IdReaction:70524
_displayNamePXLP-K314-GPT transaminates PYR to form L-Ala
_doReleaseTRUE
_timestamp2024-12-03 20:52:53
catalystActivity[CatalystActivity:70522] L-alanine:2-oxoglutarate transaminase activity of PXLP-K314-GPT dimer [cytosol]
catalystActivityReference[CatalystActivityReference:9643950] L-alanine:2-oxoglutarate aminotransferase activity of GPT dimer [cytosol] cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase
compartment[Compartment:70101] cytosol
crossReference[DatabaseIdentifier:9925793] RHEA:19455
input[SimpleEntity:29398] PYR [cytosol]
[SimpleEntity:29404] L-Glu [cytosol]
literatureReference[LiteratureReference:507765] Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods
[LiteratureReference:199767] Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites.
[LiteratureReference:507751] cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase
modified[InstanceEdit:156746] D'Eustachio, P, 2004-12-09 17:18:23
[InstanceEdit:163376] Vastrik, I, 2005-04-29 06:26:51
[InstanceEdit:199761] D'Eustachio, P, 2007-07-11 22:14:00
[InstanceEdit:450682] D'Eustachio, P, 2009-12-16
[InstanceEdit:507750] D'Eustachio, P, 2010-02-08
[InstanceEdit:517476] D'Eustachio, P, 2010-02-18
[InstanceEdit:8946993] Shorser, Solomon, 2016-11-07
[InstanceEdit:9643047] Wu, G, 2019-04-04
[InstanceEdit:9644835] Jassal, Bijay, 2019-04-25
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
[InstanceEdit:9925801] D'Eustachio, Peter, 2024-10-25
[InstanceEdit:9930378] D'Eustachio, Peter, 2024-12-03
namePXLP-K314-GPT transaminates PYR to form L-Ala
pyruvate + glutamate <=> alanine + alpha-ketoglutarate [GPT]
negativePrecedingEvent[NegativePrecedingEvent:9930369] Futile Cycle: PXLP-K314-GPT transaminates L-Ala to form PYR
output[SimpleEntity:29432] L-Ala [cytosol]
[SimpleEntity:29406] 2OG [cytosol]
releaseDate2004-07-06
reverseReaction
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:361758] R-HSA-70524.6
summation[Summation:179127] Cytosolic glutamic-pyruvate transaminase (alanine aminotrans...
(hasEvent)[Pathway:8964540] Alanine metabolism [Homo sapiens]
(precedingEvent)[NegativePrecedingEvent:9930399] Futile Cycle: PXLP-K314-GPT transaminates PYR to form L-Ala
(replacementInstances)[_Deleted:507778] Deletion of instance: 70525
(reverseReaction)[Reaction:70523] PXLP-K314-GPT transaminates L-Ala to form PYR [Homo sapiens]
(updatedInstance)[_UpdateTracker:9790822] Update Tracker - [Reaction:70524] PXLP-K314-GPT transaminates PYR to form L-Ala - v32:[addLiteratureReference, modifyText]
[_UpdateTracker:9792299] Update Tracker - [Reaction:70524] PXLP-K314-GPT transaminates PYR to form L-Ala - v22:[addLiteratureReference]
[Change default viewing format]
No pathways have been reviewed or authored by PXLP-K314-GPT transaminates PYR to form L-Ala (70524)
Follow Reactome